4
Changes in Ownership
Mereo BioPharma Group plc Filed Acc 0000950170-25-009794
Options or other derivatives
- Chief Scientific Officer acquired 116,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lewicki John A. · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-25 | Grant or award : show line 1 in the form Share Options (Right to buy) | +116,000 | 116,000 | D |
Loading xslF345X05/ownership.xml…